Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient
Scleroderma
2 other identifiers
observational
50
0 countries
N/A
Brief Summary
To determine sleep disturbance, pulmonary function test, 6 minute walk, echocardiogram abnormality, arterial blood gas, ventilation/perfusion scan of the chest in Scleroderma patient with Pulmonary Hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2006
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 29, 2007
CompletedFirst Posted
Study publicly available on registry
December 3, 2007
CompletedMarch 9, 2010
March 1, 2010
November 29, 2007
March 8, 2010
Conditions
Keywords
Eligibility Criteria
Males, Females and Minorities Age range of subjects 18-75 years old
You may qualify if:
- Patient must have Scleroderma
You may not qualify if:
- Patients who do not have Scleroderma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwell Healthlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arunabh Talwar, MD
Northwell Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 29, 2007
First Posted
December 3, 2007
Study Start
February 1, 2006
Study Completion
February 1, 2007
Last Updated
March 9, 2010
Record last verified: 2010-03